Wiebe Braam

1.1k total citations
18 papers, 690 citations indexed

About

Wiebe Braam is a scholar working on Endocrine and Autonomic Systems, Genetics and Cognitive Neuroscience. According to data from OpenAlex, Wiebe Braam has authored 18 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrine and Autonomic Systems, 7 papers in Genetics and 6 papers in Cognitive Neuroscience. Recurrent topics in Wiebe Braam's work include Circadian rhythm and melatonin (8 papers), Sleep and related disorders (6 papers) and Sleep and Wakefulness Research (5 papers). Wiebe Braam is often cited by papers focused on Circadian rhythm and melatonin (8 papers), Sleep and related disorders (6 papers) and Sleep and Wakefulness Research (5 papers). Wiebe Braam collaborates with scholars based in Netherlands, China and France. Wiebe Braam's co-authors include Marcel G. Smits, Leopold Curfs, Robert Didden, Ingeborg M. van Geijlswijk, Hubert Korzilius, Henry Keijzer, Karen Spruyt, Daniel Alonso‐Alconada, Oliviero Bruni and Valérie Biran and has published in prestigious journals such as Sleep Medicine Reviews, Developmental Medicine & Child Neurology and Sleep Medicine.

In The Last Decade

Wiebe Braam

18 papers receiving 667 citations

Peers

Wiebe Braam
Timothy F. Hoban United States
TC Britton United Kingdom
Ashura Buckley United States
Christa J. Anderson United States
Antonina Scarnà United Kingdom
Wiebe Braam
Citations per year, relative to Wiebe Braam Wiebe Braam (= 1×) peers Henriette Charbuy

Countries citing papers authored by Wiebe Braam

Since Specialization
Citations

This map shows the geographic impact of Wiebe Braam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiebe Braam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiebe Braam more than expected).

Fields of papers citing papers by Wiebe Braam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiebe Braam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiebe Braam. The network helps show where Wiebe Braam may publish in the future.

Co-authorship network of co-authors of Wiebe Braam

This figure shows the co-authorship network connecting the top 25 collaborators of Wiebe Braam. A scholar is included among the top collaborators of Wiebe Braam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiebe Braam. Wiebe Braam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Braam, Wiebe & Karen Spruyt. (2022). Reference intervals for 6-sulfatoxymelatonin in urine: A meta-analysis. Sleep Medicine Reviews. 63. 101614–101614. 9 indexed citations
2.
Braam, Wiebe, et al.. (2018). Low maternal melatonin level increases autism spectrum disorder risk in children. Research in Developmental Disabilities. 82. 79–89. 40 indexed citations
3.
Spruyt, Karen, Wiebe Braam, & Leopold Curfs. (2017). Sleep in Angelman syndrome: A review of evidence. Sleep Medicine Reviews. 37. 69–84. 34 indexed citations
4.
Spruyt, Karen, Wiebe Braam, Marcel G. Smits, & Leopold Curfs. (2016). Sleep Complaints and the 24‐h Melatonin Level in Individuals with Smith–Magenis Syndrome: Assessment for Effective Intervention. CNS Neuroscience & Therapeutics. 22(11). 928–935. 23 indexed citations
5.
Bruni, Oliviero, Daniel Alonso‐Alconada, Frank Besag, et al.. (2014). Current role of melatonin in pediatric neurology: Clinical recommendations. European Journal of Paediatric Neurology. 19(2). 122–133. 178 indexed citations
6.
Smits, Marcel G., Henry Keijzer, Wiebe Braam, Jacques Vervoort, & Leopold Curfs. (2013). Personalized sleep medicine applied to melatonin treatment for circadian rhythm sleep disorders: current status and future. Sleep Medicine. 14. e271–e271. 2 indexed citations
7.
Braam, Wiebe, Henry Keijzer, Harry Struijker Boudier, et al.. (2012). CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?. Journal of Intellectual Disability Research. 57(11). 993–1000. 58 indexed citations
8.
Didden, Robert, Hubert Korzilius, Wiebe Braam, et al.. (2011). Psychometric properties of a sleep questionnaire for use in individuals with intellectual disabilities. Research in Developmental Disabilities. 32(6). 2467–2479. 26 indexed citations
9.
Braam, Wiebe, Ingeborg M. van Geijlswijk, Henry Keijzer, et al.. (2010). Loss of response to melatonin treatment is associated with slow melatonin metabolism. Journal of Intellectual Disability Research. 54(6). 547–555. 75 indexed citations
10.
Braam, Wiebe, Marcel G. Smits, Robert Didden, et al.. (2009). Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta‐analysis. Developmental Medicine & Child Neurology. 51(5). 340–349. 94 indexed citations
11.
Braam, Wiebe, et al.. (2009). Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia. Journal of Intellectual Disability Research. 54(1). 52–59. 10 indexed citations
12.
Didden, Robert, et al.. (2009). Sleep in individuals with Cri du Chat syndrome: a comparative study. Journal of Intellectual Disability Research. 53(8). 704–715. 13 indexed citations
13.
Grossfeld, Paul, Robert Didden, Hubert Korzilius, et al.. (2008). Sleep problems in individuals with 11q terminal deletion disorder (Jacobsen syndrome).. PubMed. 19(2). 225–35. 8 indexed citations
14.
Braam, Wiebe, Marcel G. Smits, Robert Didden, & Leopold Curfs. (2008). Melatonin is effective in treating sleep problems in Angelman syndrome but problems in metabolising melatonin may be part of the Angelman phenotype. Journal of Intellectual Disability Research. 52(10). 814–814. 4 indexed citations
15.
Braam, Wiebe, Robert Didden, Marcel G. Smits, & Leopold Curfs. (2007). Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo‐controlled study. Journal of Intellectual Disability Research. 52(3). 256–264. 39 indexed citations
16.
Braam, Wiebe, Robert Didden, Marcel G. Smits, & Leopold Curfs. (2007). Melatonin for Chronic Insomnia in Angelman Syndrome: A Randomized Placebo-Controlled Trial. Journal of Child Neurology. 23(6). 649–654. 73 indexed citations
17.
Braam, Wiebe, et al.. (2007). Normal sleep duration, but increased time in bed in individuals with profound/severe intellectualdisabilitywholivein a residential facility. Data Archiving and Networked Services (DANS). 18. 45–47. 1 indexed citations
18.
Braam, Wiebe, et al.. (2006). Sleep and sleep problems in Angelman syndrome and Prader-Willi syndrome. Birth Defects Research. 81–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026